Skip to Main Content

Mahdi Garelnabi

Mahdi Garelnabi
Mahdi O. Garelnabi Associate Professor

Expertise

Clinical Chemistry, Biochemistry of Lipids and Lab Instrumentation

Research Interests

Atherosclerosis; Lipoprotein; Inflammation, antioxidants, oxidative stress, cardiovascular diseases, reproductive medicine, fertility; In vitro fertilization, laboratory medicine & analytical method validation. Nutrition and Population Health

Atherosclerosis is a chronic disease in which modified lipid derivatives and cell infiltrations are mediated through a complex inflammatory process leading to plaque and tissue build up within the coronary arteries. This is the underlying cause of the majority of clinical cardiovascular events, which is the leading cause of death in the USA and around the world. Our Research Group focuses on the understanding of the role of lipids and its metabolites on atherosclerosis and lipoproteins metabolism. The group is also interested in obesity studies and the involvement of adipose biomarkers on atherosclerosis and other related chronic disorder. In addition the group is interested in studies on the role of indoor air pollution. The group research lab performs basic research experiments using cell culture, animal models and clinical studies. These studies involve dietary, antioxidants and therapeutic supplements targeting specific pathways of inflammation and oxidative stress. We are also interested in new clinical laboratory method development and validation.

Education

  • Basic of Mass Spectrometry Theory, (2011), American Association of Clinical Chemistry - USA
  • Clinical Laboratory Leadership & Management, (2010), American Association of Clinical Chemistry - USA
  • Point of Care Testing, (2009), American Association of Clinical Chemistry - USA
  • Ph D: Clinical Biochemistry, (2001), M.A. Medical College, Delhi University - India
  • MS: Clinical Biochemistry, (1994), Grant Medical College, Bombay University - India
  • Nutrition & Dietetics (DND), (1993), Institute of Health Care Administration - India
  • Medical Laboratory Technology (MLT)., (1990), The Bombay School of Medical Laboratory Technology - Bombay (India)
  • BS: Biology, (1987), Faculty of Education

Biosketch

Garelnabi received a Master of Science in Clinical Biochemistry from Bombay University and a doctoral degree in Clinical Biochemistry from Delhi University, India. He joined a postdoctoral fellowship in cardiovascular disease and lipoprotein pathophysiology at Emory University; and later joined The Ohio State University as a research scientist. He briefly joined Siemens Healthcare Diagnostic as a Senior Scientist at the Department of Medical and Clinical Affairs before join the University of Massachusetts. Presently Garelnabi is an Associate Professor at the department of Biomedical and Nutritional Sciences, University of Massachusetts Lowell. Garelnabi authored several scientific articles and book chapters and presented his research work at National and International meetings. He is an editorial board member and a reviewer for several scientific journals. In addition; Garelnabi is an active member and contributor to many scientific and professional organizations including the American Heart Association council of Atherosclerosis, Thrombosis and vascular Biology; the American Association for Clinical Chemistry, the National Lipids Association and the European Atherosclerosis Society.

Selected Awards and Honors

  • AACC Northeast Section Outstanding Service Award (2017), Service, Professional - American Associate for Clinical Chemistry
  • The BNS Teaching Excellence Award for the 2015-2016. (2016), Teaching - Department of Biomedical and Nutritional Sciences
  • Fellow (2014) - American Heart Association
  • Junior Investigator Travel Award (2005) - NAVBO, USA.
  • Senior Research Fellowship Award (2000), Scholarship/Research - UGC, India
  • Junior Research Fellowship Award (1998), Scholarship/Research - UGC, India

Selected Publications

  • Garelnabi, M.O., Litvinov, D., Parthasarathy, S. (). Evaluation of a gas chromatography method for azelaic acid determination in selected biological samples. North American Journal of Medical Sciences, 397-402.
  • Garelnabi, M.O., E., J., Veledar, E. (). Platelet Activation in Ischemic Heart Disease: Role of Modulators and New Therapies. InTech
  • Garelnabi, M.O., Kakumanu, S., Litvinov, D. (). Role of Oxidized Lipids in Atherosclerosis. InTech
  • Wu, T., Mazhar, Z., Alsayrafi, D., Garelnabi, M.O. (2020). p-Cymene Modulate Oxidative Stress and Inflammation in Murine Macrophages: Potential Implication in Atherosclerosis. Cardiovascular & Hematological Agents in Medicinal Chemistry, 18(2) 151-157.
  • Bardon, K.M., Garelnabi, M.O. (2020). The impact of altered mechanobiology on aortic valve pathophysiology. Archives of Biochemistry and Biophysics, 691 108463.
  • McGrail, L., Garelnabi, M.O. (2020). Polyphenolic Compounds and Gut Microbiome in Cardiovascular Diseases. Current Pharmaceutical Biotechnology, 21(7) 578-586.
  • Piper, K., Garelnabi, M.O. (2020). Eicosanoids: Atherosclerosis and cardiometabolic health. Journal of Clinical & Translational Endocrinology, 19 100216.
  • Amin, K.A., Homeida, A.M., ElMazoudy, R.H., Hashim, K.S., Garelnabi, M.O. (2020). Corrigendum to “Dietary Lipids in Health and Disease”. Journal of Lipids, 2020 1-1.
  • Amin, K.A., Homeida, A.M., El Mazoudy, R.H., Hashim, K.S., Garelnabi, M.O. (2019). Dietary Lipids in Health and Disease. Journal of Lipids, 2019 1-2.
  • Garelnabi, M.O., Mahini, H. (2018). Role of polyphenolic flavonoid and exercise in atherosclerosis. Free Radical Biology and Medicine, 128 S26.
  • Ochin, C., Garelnabi, M.O. (2018). Dietary Oxidized Lipids Deferentially Modulate Inflammation. Atherosclerosis Supplements, 32 92.
  • Ochin, C., Garelnabi, M.O. (2018). Abstract 386: Dietary Oxidized Linoleic Acid Modulates PCSK9 and Associated Genes. Arteriosclerosis, Thrombosis, and Vascular Biology, 38(Suppl_1).
  • Veledar, E., Saxena, A., Arias, L., Aneni, E., Garelnabi, M.O., Nasir, K. (2018). Abstract 431: Sex Differences in Manifestation of Subclinical Coronary Atherosclerosis: Analysis of Lipoprotein Sub-Fractions in Healthy but High Risk Individuals. Arteriosclerosis, Thrombosis, and Vascular Biology, 38(Suppl_1).
  • Ochin, C.C., Garelnabi, M.O. (2018). Berberine Encapsulated PLGA-PEG Nanoparticles Modulate PCSK-9 in HepG2 Cells. Cardiovascular & Hematological Disorders-Drug Targets, 18(1) 61-70.
  • Garelnabi, M.O., Ainsworth, G., Mahini, H., Jamil, N., Ochin, C. (2017). Dietary Oxidized Linoleic Acid Modulates Plasma Lipids beyond Triglycerides Metabolism. Journal of Lipids, 2017 1-7.
  • Mazhar, Z., Hughes, A., Garelnabi, M.O. (2017). Targeting the Role of Lipoprotein (a) in Stroke. Cardiovascular & Hematological Disorders-Drug Targets, 17(1).
  • Ochin, C., Garelnabi, M.O. (2017). Glycerophospholipid Fatty Acids GC-MS Analysis in Mice Fed Oxidized Linoleic Acids. Journal of Clinical Lipidology, 11(3) 826-827.
  • Mazhar, Z., Alsayrafi, D., Wu, T., Garelnabi, M.O. (2016). Di-n-butyl Phthalate: An Indoor Pollutant Induces Murine Macrophages Oxidative Stress and Inflammation, a Potential Atheropathogenesis Modulator. Biol: supplement.
  • Garelnabi, M.O., Ainsworth, G. (2016). Dietary Oxidized Linoleic Acid Ameliorate Plasma ApoA5 levels in C57BL mice. Journal of Clinical Lipidology, 10(3) 705.
  • Chinedu, C.O., Garelnabi, M.O. (2016). Novel Nanoparticles Berberine Chloride Oral Delivery Approaches Targeting PCSK9. Biol: supplement.
  • Mahini, H., Alsayrafi, D., Wu, T., Garelnabi, M.O. (2016). Strenuous Exercise and Quercetin Intake Differentially Modulate PCSK9 and ANGPLT4 in Normal C57BL6 Mice. Biol: supplement
  • Garelnabi, M.O., Ainsworth, G. (2016). Dietary Oxidized Linoleic Acid Ameliorate Plasma ApoA5 levels in C57BL mice. Journal of Clinical Lipidology, 10(3) 705.
  • Wu, T., Mazhar, Z., Alsayrafi, D., Ainsworth, G., Garelnabi, M.O. (2015). 117 - p-Cymene Modulate Oxidative Stress and Inflammation Genes in Murine Macrophage. Free radical biology & medicine, 87 S59-S60.
  • Ainsworth, G., Mahini, H., Alaimo, H., Jamil, N., Garelnabi, M.O. (2015). Effect of oxidized linoleic acid on plasma apoC 3 levels in C57BL mice. The FASEB Journal, 29(1 Supplement) 568.31.
  • Ainsworth, G., Mahini, H., Garelnabi, M.O. (2015). Oxidized Linoleic Acid Modulates Plasma Lipids and Associated Apolipoproteins in C57bl Mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 35(Suppl 1) A539-A539.
  • Mahini, H., Ainsworth, G., Garelnabi, M.O. (2015). Strenuous exercise and quercetin intake stimulates aortic NFkB signaling. The FASEB Journal, 29(1 Supplement) 568.10.
  • Stella, A., Hsieh, S., Garelnabi, M.O., Horta, J., Rogers, E.J. (2015). Adsorption of Homocysteine to Various Polymorphs of Titanium (IV) Oxide. Adsorption Science & Technology.
  • Wu, T., Mazhar, Z., Alsayrafi, D., Ainsworth, G., Garelnabi, M.O. (2015). p-Cymene Modulate Oxidative Stress and Inflammation Genes in Murine Macrophage. Free Radical Biology and Medicine, 87 S59-S60.
  • Garelnabi, M.O., Younis, A. (2015). Paraoxonase-1 enzyme activity assay for clinical samples: validation and correlation studies. Medical science monitor : international medical journal of experimental and clinical research, 21 902-908.
  • Garelnabi, M.O., Mahini, H., Wilson, T.A. (2014). Quercetin intake with exercise modulates lipoprotein metabolism and reduces atherosclerosis plaque formation. Journal of the International Society of Sports Nutrition, 11(1).
  • Stella, A., Hsieh, S., Garelnabi, M.O., Horta, J.E., Rogers, E. (2014). Determination of Aminothiol Adsorption Properties of Nano-Sized Titanium (IV) Oxide by HPLC-FLD. Clinical Chemistry, 60(10 (Suppl)) B-433.
  • Mahini, H., Ainsworth, G., Garelnabi, M.O. (2014). Exercise and quercetin intake reduces body weight in c57bl6 mice. Atherosclerosis, 235(2) e109-e110.
  • Garelnabi, M.O., Mahini, H., Ainsworth, G. (2014). Flavonoids and exercise but not the combination enhances plasma catalase levels in C57BL mice. Atherosclerosis, 235(2) e248.
  • Garelnabi, M.O., Younis, A. (2014). Paraoxonase-1 Enzyme Activity Assay for Clinical Samples: Validation and Correlation Studies. Clinical Chemistry, 60(10 (Suppl)) B-318.
  • Mahini, H., Ainsworth, G., Garelnabi, M.O. (2014). Rigorous Exercise and Quercetin Intake Modulate Adiponectin and Reduce Body Weight in Normal C57BL6 Mice. Arteriosclerosis, Thrombosis, & Vascular Biology, P615 (Suppl).
  • Younis, A., Hawkins, K., Mahini, H., Butler, W., Garelnabi, M.O. (2014). Serum tumor necrosis factor-α, interleukin-6, monocyte chemotactic protein-1 and paraoxonase-1 profiles in women with endometriosis, pcos, or unexplained infertility. Journal of Assisted Reproduction and Genetics, 31(11) 1445-1451.
  • Younis, A., Hawkins, K., Mahini, H., Butler, W., Garelnabi, M.O. (2014). Serum tumor necrosis factor-α, interleukin-6, monocyte chemotactic protein-1 and paraoxonase-1 profiles in women with endometriosis, pcos, or unexplained infertility. Journal of Assisted Reproduction and Genetics, 31(11) 1445-1451.
  • Garelnabi, M.O., Younis, A. (2014). Paraoxonase-1 Enzyme Activity Assay for Clinical Samples: Validation and Correlation Studies. Medical Science Monitor.
  • Abdelmoneim, Y.S., Clower, C., Nelsen, D., Butler, W., Mahini, H., Garelnabi, M.O. (2014). Associations of necrosis factor-a, interluekin-6, monocyte chemotactic protein-1 and Paraoxonase-1 with endometriosis, PCOS, or unexplained Infertility during ovarian simulation. Journal of Assisted Reproduction and Genetics.
  • Mahini, H., Ainsworth, G., Garelnabi, M.O. (2014). Exercise and quercetin intake reduces body weight in c57bl6 mice. Atherosclerosis, 235(2) e109-e110.
  • Garelnabi, M.O., Mahini, H., Ainsworth, G. (2014). Flavonoids and exercise but not the combination enhances plasma catalase levels in C57BL mice. Atherosclerosis, 235(2) e248.
  • Stella, A., Hsieh, S., Garelnabi, M.O., Horta, J.E., Rogers, E.J. (2014). Determination of Aminothiol Adsorption Properties of Titanium(IV) Oxide Nanoparticles Using High-Performance Liquid Chromatography Fluorescence Detection. Adsorption Science & Technology, 32(7) 591-604.
  • Stella, A., Hsieh, S., Garelnabi, M.O., Horta, J.E., Rogers, E.J. (2014). Determination of Aminothiol Adsorption Properties of Titanium(IV) Oxide Nanoparticles Using High-Performance Liquid Chromatography Fluorescence Detection (32:7 pp. 591). Adsorption Science & Technology
  • Garelnabi, M.O., Mahini, H. (2014). Modulation of microRNA 21, 125 b and 451 expression by quercetin intake and exercise in mice fed atherogenic diet. Biomedicine & Preventive Nutrition, 4(3) 359-363.
  • Garelnabi, M.O., Mahini, H. (2014). Modulation of microRNA 21, 125 b and 451 expression by quercetin intake and exercise in mice fed atherogenic diet. Biomedicine and Preventive Nutrition, 4(3) 359-363.
  • Garelnabi, M.O., Mahini, H. (2014). Beneficial effects of flavonoids on the pathogenesis of atherosclerosis. 8th World Congress on Polyphenols Applications
  • Garelnabi, M.O. (2014). Effects of quercetin on microRNA signaling associated with atherosclerosis. 8th World Congress on Polyphenols Applications
  • Mahini, H., Ainsworth, G., Garelnabi, M.O. (2014). Exercise and quercetin intake reduces body weight in C57BL mice. Atherosclerosis, 235(2) e109-e110.
  • Garelnabi, M.O., Mahini, H., Ainsworth, G. (2014). Flavonoids and Exercise but not the combination enhances plasma catalase levels in C57BL6 mice. Atherosclerosis, 235(2) e248.
  • Garelnabi, M.O., Mahini, H., Wilson, T.A. (2014). Quercetin intake with exercise modulates lipoprotein metabolism and reduces atherosclerosis plaque formation. Journal of the International Society of Sports Nutrition, 11(1).
  • Garelnabi, M.O., Mahini, H. (2013). Quercetin Intake Differentially Affects the Plasma Lipid Levels and Lipoproteins Associated Gene Expression in Normal C57b1 Female Mice. Circulation, 127 AP426.
  • Garelnabi, M.O., Mahini, H., Massie, M., Cook, C., Santanam, N. (2013). Quercetin Intake with Exercise Modulate Adipose Response in Mice Fed Atherogenic Diet. Arteriosclerosis, Thrombosis, & Vascular Biology, P136 (Suppl).
  • Garelnabi, M.O., Uzoigwe, J., Prum, T., Bresnahan, E. (2013). The emerging role of outdoor and indoor air pollution in cardiovascular disease. North American Journal of Medical Sciences, 5(8) 445.
  • Younis, A., Hawkins, K., Dizer, S., Hughes, A., Butler, W., Garelnabi, M.O. (2013). Ovarian stimulation for IUI-IVF alter cytokine, chemokine, and antioxidant levels in women with endometriosis, PCOS, or unexplained infertility. Fertility and Sterility, 100(3) S425 (Suppl).
  • Uzoigwe, J., Prum, T., Bresnahan, E., Garelnabi, M.O. (2013). The Emerging Role of Outdoor and Indoor Air Pollution in Cardiovascular Disease. North American Journal of Medical Sciences, 5(8) 445-453.
  • Garelnabi, M.O., Mahini, H. (2013). Effect of Myricetin treatment on lipoprotein metabolism in 13-HODE exposed HepG2 cells. A-547-0009-00535, 81st European Atherosclerosis Society Congress
  • Garelnabi, M.O., Mahini, H. (2013). Exercise mediates selected microRNA expression and promosotes plaque regression. A-547-0013-00913, 81st European Atherosclerosis Society Congress
  • Garelnabi, M.O., Lor, K., Jin, J., Chai, F., Santanam, N. (2013). The paradox of ApoA5 modulation of triglycerides: Evidence from clinical and basic research. Clinical Biochemistry, 46(1-2) 12-19.
  • Garelnabi, M.O., Lor, K., Jin, J., Chai, F., Santanam, N. (2013). The paradox of ApoA5 modulation of triglycerides: Evidence from clinical and basic research. Clinical Biochemistry, 46(1-2) 12-19.
  • Garelnabi, M.O., Litvinov, D., Mahini, H. (2012). Antioxidant and anti-inflammatory role of paraoxonase 1: Implication in arteriosclerosis diseases. North American Journal of Medical Sciences, 4(11) 523.
  • Garelnabi, M.O., Horta, J.E., Veledar, E. (2012). Platelet Activation in Ischemic Heart Disease: Role of Modulators and New Therapies.
  • Garelnabi, M.O., Kakumanu, S., Litvinov, D. (2012). Role of Oxidized Lipids in Atherosclerosis.
  • Younis, A., Clower, C., Nelsen, D., Butler, W., Carvalho, A., Hok, E., Garelnabi, M.O. (2012). The relationship between pregnancy and oxidative stress markers on patients undergoing ovarian stimulations. Journal of assisted reproduction and genetics, 1-7.
  • Garelnabi, M.O., Veledar, E., White-Welkley, J., Santanam, N., Abramson, J., Weintraub, W., Parthasarathy, S. (2012). Vitamin E differentially affects short term exercise induced changes in oxidative stress, lipids, and inflammatory markers. Nutrition, Metabolism & Cardiovascular Diseases, 22(10) 907-913.
  • Younis, A., Clower, C., Nelsen, D., Butler, W., Carvalho, A., Hok, E., Garelnabi, M.O. (2012). The relationship between pregnancy and oxidative stress markers on patients undergoing ovarian stimulations. Journal of Assisted Reproduction and Genetics, 29(10) 1083-1089.
  • Garelnabi, M.O., Gupta, V., Mallika, V., Bhattacharjee, J. (2011). Platelet Nitric Oxide Signaling System in Patients with Coronary Artery Disease. Annals of Vascular Diseases, 4(2) 99-105.
  • Younis, A., Clower, C., Nelsen, D., Butler, W., Garelnabi, M.O. (2011). The Relationship between Pregnancy and Oxidative Stress Markers on Patients Undergoing Ivf/iui. Fertility and sterility, 96(3).
  • Garelnabi, M.O., Veledar, E., White-Welkley, J., Santanam, N., Abramson, J., Weintraub, W., Parthasarathy, S. (2011). Vitamin E differentially affects short term exercise induced changes in oxidative stress, lipids, and inflammatory markers. Nutrition, Metabolism and Cardiovascular Diseases.
  • Younis, A., Clower, C., Nelsen, D., Butler, W., Garelnabi, M.O. (2011). The relationship between pregnancy and oxidative stress markers on patients undergoing IVF/IUI. Fertility and Sterility, 96(3) S241-S242.
  • Garelnabi, M.O. (2010). Emerging evidences from the contribution of the traditional and new risk factors to the atherosclerosis pathogenesis. Journal of Medical Sciences, 10(6) 153-161.
  • Garelnabi, M.O., Litvinov, D., Parthasarathy, S. (2010). Evaluation of a gas chromatography method for azelaic acid determination in selected biological samples. North American Journal of Medical Sciences, 2(9).
  • Parthasarathy, S., Raghavamenon, A., Garelnabi, M.O., Santanam, N. (2010). Oxidized Low-Density Lipoprotein (pp. 403-417). Humana Press
  • Garelnabi, M.O., Veledar, E., Abramson, J., White-Welkley, J., Santanam, N., Weintraub, W., Parthasarathy, S. (2010). Physical inactivity and cardiovascular risk: Baseline observations from men and premenopausal women. Journal of clinical laboratory analysis, 24(2) 100-105.
  • Garelnabi, M.O., Gupta, V., Mallika, V., Bhattacharjee, J. (2010). Platelets oxidative stress in Indian patients with ischemic heart disease. Journal of Clinical Laboratory Analysis, 24(1) 49-54.
  • Garelnabi, M.O., Gupta, V., Mallika, V., Bhattacharjee, J. (2010). Platelets oxidative stress in Indian patients with ischemic heart disease. Journal of clinical laboratory analysis, 24(1) 49-54.
  • Garelnabi, M.O. (2010). Emerging Evidences from the Contribution of the Traditional and New Risk Factors to the Atherosclerosis Pathogenesis. Journal of Medical Sciences(Faisalabad), 10(6) 153-161.
  • Litvinov, D., Selvarajan, K., Garelnabi, M.O., Brophy, L., Parthasarathy, S. (2010). Anti-atherosclerotic actions of azelaic acid, an end product of linoleic acid peroxidation, in mice. Atherosclerosis, 209(2) 449-454.
  • Garelnabi, M.O., Veledar, E., Abramson, J., White-Welkley, J., Santanam, N., Weintraub, W., Parthasarathy, S. (2010). Physical inactivity and cardiovascular risk: baseline observations from men and premenopausal women. Journal of Clinical Laboratory Analysis, 24(2) 100-105.
  • Parthasarathy, S., Raghavamenon, A., Garelnabi, M.O., Santanam, N. (2010). Oxidized low-density lipoprotein. Methods in molecular biology (Clifton, N.J.), 610 403-17.
  • Parthasarathy, S., Raghavamenon, A., Garelnabi, M.O., Santanam, N. (2010). Oxidized low-density lipoprotein. Methods in molecular biology (Clifton, N.J.), 610 403-17.
  • Raghavamenon, A., Garelnabi, M.O., Babu, S., Aldrich, A., Litvinov, D., Parthasarathy, S. (2009). α-Tocopherol Is Ineffective in Preventing the Decomposition of Preformed Lipid Peroxides and May Promote the Accumulation of Toxic Aldehydes: A Potential Explanation for the Failure of Antioxidants to Affect Human Atherosclerosis. Antioxidants & Redox Signaling, 11(6) 1237-1248.
  • Jaichander, P., Selvarajan, K., Garelnabi, M.O., Parthasarathy, S. (2008). Induction of paraoxonase 1 and apolipoprotein A1 gene expression by aspirin. Journal of lipid research, 49 2142-2148.
  • Garelnabi, M.O., Brown, W.V., Le, N. (2008). Evaluation of a novel colorimetric assay for free oxygen radicals as marker of oxidative stress. Clinical Biochemistry, 41(14-15) 1250-1254.
  • Jaichander, P., Selvarajan, K., Garelnabi, M.O., Parthasarathy, S. (2008). Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin. Journal of Lipid Research, 49(10) 2142-2148.
  • Garelnabi, M.O., Brown, W.V., Le , N.A. (2008). Evaluation of a novel colorimetric assay for free oxygen radicals as marker of oxidative stress. Clinical biochemistry, 41(14-15) 1250-4.
  • Garelnabi, M.O., Brown, W.V., Le , N.A. (2008). Evaluation of a novel colorimetric assay for free oxygen radicals as marker of oxidative stress. Clinical biochemistry, 41(14-15) 1250-4.
  • Garelnabi, M.O., Selvarajan, K., Litvinov, D., Santanam, N., Parthasarathy, S. (2008). Dietary oxidized linoleic acid lowers triglycerides via APOA5/APOClll dependent mechanisms. Atherosclerosis, 199(2) 304-309.
  • Parthasarathy, S., Litvinov, D., Selvarajan, K., Garelnabi, M.O. (2008). Lipid peroxidation and decomposition — Conflicting roles in plaque vulnerability and stability. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1781(5) 221-231.
  • Wei, C., Penumetcha, M., Santanam, N., Liu, Y., Garelnabi, M.O., Parthasarathy, S. (2005). Exercise might favor reverse cholesterol transport and lipoprotein clearance: Potential mechanism for its anti-atherosclerotic effects,. Biochimica et Biophysica Acta 1723, 124-127.
  • Wei, C., Penumetcha, M., Santanam, N., Liu, Y., Garelnabi, M.O., Parthasarathy, S. (2005). Exercise might favor reverse cholesterol transport and lipoprotein clearance: Potential mechanism for its anti-atherosclerotic effects. Biochimica et Biophysica Acta (BBA) - General Subjects, 1723(1-3) 124-127.